Why the study?
Pregnancy induces profound hemodynamic changes impactful in cardiovascular disease, requiring clinical assessment supplemented by cardiac imaging to protect both mother and fetus.
This review summarizes the role of multimodality cardiovascular imaging in the management of pregnant women with valvulopathy, hypertrophic cardiomyopathy, and aortopathy.
Imaging augments pre- to postpartum CVD care; leaves open standardized fetal-risk protocols.
Pregnancy is associated with profound hemodynamic changes that are particularly impactful in patients with underlying cardiovascular disease. Management of pregnant women with cardiovascular disease requires careful evaluation that considers the well-being of both the woman and the developing fetus. Clinical assessment begins before pregnancy and continues throughout gestation into the post-partum period and is supplemented by cardiac imaging. This review discusses the role of imaging, specifically echocardiography, cardiac MRI, and cardiac CT, in pregnant women with valvular diseases, hypertrophic cardiomyopathy, and aortic pathology.
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: